Gyre Therapeutics posts updated corporate presentation; specific content not available in filing excerpt

GYRE THERAPEUTICS, INC.

Presentation dated June 2026 made available on company's website on June 1, 2026.
Presentation describes Gyre as a biopharma company focused on fibrosis, inflammatory diseases, and cancer.
Filing includes only the title slide; full presentation content is not included in the provided exhibit text.
Investors should refer to the full presentation on the company's website for detailed updates.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.